C
ANVS icon

Covestor’s Annovis Bio ANVS Stock Holding History

Covestor’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
4,634
+2,289
+98% +$4.45K 0.01% 1639
2026
Q1 		$5K Buy
2,345
+6
+0.3% +$16 ﹤0.01% 1772
2025
Q4 		$8K Hold
2,339
– – ﹤0.01% 1672
2025
Q3 		$5K Hold
2,339
– – ﹤0.01% 1843
2025
Q2 		$5K Buy
2,339
+463
+25% +$914 ﹤0.01% 1742
2025
Q1 		$3K Buy
+1,876
New +$5.74K ﹤0.01% 1767

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Covestor's ANVS Position: Q2 2026 in Review

Covestor increased its Annovis Bio (ANVS) stake by 98% in Q2 2026, buying an estimated $4.45K and bringing the position to 4,634 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1639.

Covestor first reported a position in ANVS in Q1 2025 and has held it in 6 quarters since. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Covestor held 4,634 shares of Annovis Bio worth $9K as of Q2 2026.
  • Covestor bought 2,289 Annovis Bio shares in Q2 2026, an estimated $4.45K.
  • Annovis Bio made up 0.01% of Covestor's portfolio in Q2 2026, its #1639 holding.
  • Covestor first reported a position in Annovis Bio in Q1 2025 and has held it in 6 quarters since.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.